PMID: 6113794Jul 1, 1981Paper

Clinical pharmacology of ORG NC45 (NorcuronTM): a new nondepolarizing muscle relaxant

Anesthesiology
M R FaheyP Gencarelli

Abstract

To determine the neuromuscular effects of a new muscle relaxant, ORG NC45 (Norcuron), a monoquaternary homologue of pancuronium, 84 ASA Class I or II patients were studied under halothane and nitrous oxide anesthesia. The ED50 (dose of muscle relaxant causing a 50% depression of twitch tension) of pancuronium and ORG NC45 was 0.022 mg/kg (r = 0.90) and 0.015 mg/kg (r =0.80), respectively, for a potency ratio of 1.5 (0.022/0.015). The duration of action (time from injection to 90% recovery of control twitch tension) was 27 +/- 5 min with ORG NC45, 0.02 mg/kg, and 65 +/- 16 min with pancuronium in an equivalent dose of 0.03 mg/kg. The increase in duration of neuromuscular blockade from repetitive doses was greater with pancuronium than with ORG NC45. Reversal of an ORG NC45 neuromuscular blockade was accomplished with doses of neostigmine slightly less than those required for pancuronium. Under thiopental-nitrous oxide anesthesia, endotracheal intubation was easily performed using ORG NC45, 0.07-0.14 mg/kg. The duration of action of ORG NC45, 0.07 mg/kg, was about one-third that of pancuronium (0.1 mg/kg). It was concluded that ORG NC45 is more potent and has a shorter duration of action with both initial and repetitive doses tha...Continue Reading

Citations

Jan 1, 1991·DICP : the Annals of Pharmacotherapy·G E LarijaniA G Jacobi
Mar 1, 1991·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·M Abdulatif, M Naguib
May 1, 1988·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·F Donati
May 1, 1984·Canadian Anaesthetists' Society Journal·F DonatiD R Bevan
Feb 1, 1991·Anaesthesia and Intensive Care·S M ParrB J Robinson
Nov 1, 1988·Acta Anaesthesiologica Scandinavica·L I ErikssonJ B Löfström
Nov 1, 1982·Canadian Anaesthetists' Society Journal·A J CunninghamA G Watson
Nov 1, 1982·Canadian Anaesthetists' Society Journal·A WilliamsD R Bevan
Jul 1, 1986·Canadian Anaesthetists' Society Journal·M NaguibG H Absood
Sep 1, 1985·Anaesthesia·A B Powles, R Ganta
Feb 1, 1987·Anaesthesia·S A Feldman, J B Liban
Sep 1, 1984·Canadian Anaesthetists' Society Journal·D R BevanA Williams
Sep 1, 1982·Klinische Wochenschrift·J MossJ J Savarese
Sep 20, 1997·Anesthesia and Analgesia·J C Ballantyne, Y Chang
Aug 1, 1993·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·C BeauvoirF D'Athis
Nov 1, 1985·Canadian Anaesthetists' Society Journal·H K GyasiY Adu-Gyamfi
Jan 1, 1995·Acta Anaesthesiologica Scandinavica. Supplementum·C DiffenbachH Mellinghoff
Feb 1, 1995·Acta Anaesthesiologica Scandinavica·P RautomaO A Meretoja
Mar 1, 1988·Journal of Anesthesia·H ObaraS Iwai
Jan 14, 2011·The Journal of International Medical Research·K NitaharaK Higa
Sep 1, 1991·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·P FisetD R Bevan
Feb 1, 1988·Acta Anaesthesiologica Scandinavica·P Staun, C Lennmarken
Nov 1, 1992·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·M D Sharpe
May 23, 1998·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·G HallerB Bissonnette
Jan 1, 1988·Acta Anaesthesiologica Scandinavica. Supplementum·W Buzello
Mar 1, 1986·Canadian Anaesthetists' Society Journal·M NaguibG H Absood
Jan 1, 1986·International Journal of Clinical Monitoring and Computing·W S JordanM P Heining
Aug 9, 2007·Paediatric Anaesthesia·Stephen PlayforUNKNOWN United Kingdom Paediatric Intensive Care Society Sedation, Analgesia and Neuromuscular Blockade Working Group

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.